Date Range
toReport Types
Condition
See all (6)
Region of the Body
See all (8)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia
N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082
Periprosthetic bone loss post-total hip arthroplasty mitigated by bisphosphonate therapy
J Orthop Surg Res. 2018 Sep 4;13(1):225. doi: 10.1186/s13018-018-0918-7
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis
Climacteric. 2018 Apr;21(2):189-195
Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
Expert Opin Drug Saf. 2018 Apr;17(4):413-428
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
Osteoporos Int. 2016 Nov;27(11):3289-3300
Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
The effect of eldecalcitol on balence and strength in women with osteoporosis
J Bone Miner Metab. 2016 Sep;34(5):547-54
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Combination therapy improves site-specific BMD vs. teriparatide & denosumab monotherapies
J Clin Densitom. 2016 Jul-Sep;19(3):346-51
Immediate effects on bone metabolism biomarkers noted with resistance training and walking
BMC Musculoskelet Disord. 2016 Jun 8;17(1):254
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
Bone. 2016 Aug;89:52-8
Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users
Osteoporos Int. 2016 Jun;27(6):1989-98
Efficacy of combined teriparatide & denosumab vs. single-drug treatment for osteoporosis
J Clin Endocrinol Metab. 2016 May;101(5):2023-30
Efficacy of zoledronic acid following PLIF in patients with osteoporosis
Osteoporos Int. 2016 Apr;27(4):1469-76